CN Patent
CN102260311A — 制备一种a2a型腺苷受体激动剂及其多晶形物的方法
Assigned to Gilead Sciences Inc · Expires 2011-11-30 · 14y expired
What this patent protects
本发明披露了一种适合于大规模制备A 2A -腺苷受体激动剂的方法,并且还涉及该化合物的多晶形物的制备方法,以及涉及分离一种特定的多晶形物的方法。
USPTO Abstract
本发明披露了一种适合于大规模制备A 2A -腺苷受体激动剂的方法,并且还涉及该化合物的多晶形物的制备方法,以及涉及分离一种特定的多晶形物的方法。
Drugs covered by this patent
- regadenoson (Regadenoson) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.